NEW YORK (GenomeWeb News) – The National Cancer Institute has awarded GeneGo a phase II SBIR grant worth $1 million over two years related to help it discover breast cancer biomarkers, GeneGo said today.
 
The research program includes a large-scale gene-expression and genotyping study to be conducted at Mayo Clinic. GeneGo will use its MetaCore data-mining program for data analysis.
 
GeneGo said that in phase I of the grant it performed a network analysis of previously published microarray expression data.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.